open
webcast resource

EUROGIN 2015

HPV Infection and Related Cancers: Translating Research Innovations into Improved Practice

February 04, 2015 - February 07, 2015 | PALACIO DE EXPOSICIONES Y CONGRESOS DE SEVILLA

EUROGIN 2015

The EUROGIN 2015 Congress aims at developing a full review of current scientific developments in the field of cervical cancer and human papillomavirus related diseases, raising the public health profile and increasing the need for responsible health services in this area. The event endeavors to translate scientific and evidence-based research into clinical practice while highlighting the following aspects:

- Recent advances and updated scientific insights in HPV screening, testing and management 
- The impact of HPV and associated cancers on public health
- Strategies to prevent and treat HPV related diseases
- Exchanging information on early detection, new diagnostic and therapeutic procedures 
  and
 prevention strategies including screening and HPV vaccination

Speakers include international leaders from academic, government and private organizations, representatives of medical and scientific societies, as well as women's health associations who will discuss and exchange ideas on issues relevant to both individuals and public health


Presentations

A-From infection to diseases at different anatomic sites |B-New strategies & innovations in cervical cancer control |C-Management of HPV cervical diseases - the state of the art |D-HPV-associated diseases in non-cervical sites |E-How to introduce HPV testing into primary screening? |F-Surveillance and impact of HPV prophylactic vaccines in population |G-Immunotherapy of HPV-associated diseases |H-New challenges facing HPV 16 & 18 infection |How HPV knowledge has changed our pratice |I-Moving from cyto to HPV-based primary screening |J-Roadmap 2015: Management & control of HPV associated diseases |K-How HPV knowledge has changed our pratice |L-New insights in cervical cancer control |M-Potential impact of the quadrivalent, bivalent and nonavalent HPV vaccines
A-From infection to diseases at different anatomic sites
B-New strategies & innovations in cervical cancer control
C-Management of HPV cervical diseases - the state of the art
Discussion

Discussion

Management of HPV cervical diseases - the state of the art

D-HPV-associated diseases in non-cervical sites
E-How to introduce HPV testing into primary screening?
F-Surveillance and impact of HPV prophylactic vaccines in population
G-Immunotherapy of HPV-associated diseases
H-New challenges facing HPV 16 & 18 infection
How HPV knowledge has changed our pratice
I-Moving from cyto to HPV-based primary screening
J-Roadmap 2015: Management & control of HPV associated diseases
K-How HPV knowledge has changed our pratice
Anus

Anus

How HPV knowledge has changed our pratice: screening and management of neoplastic lesions

Anus

Anus

How HPV knowledge has changed our pratice: screening and management of neoplastic lesions

Discussion

Discussion

How HPV knowledge has changed our pratice: current and future vaccines

L-New insights in cervical cancer control
M-Potential impact of the quadrivalent, bivalent and nonavalent HPV vaccines